CRDL-PR-17 Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial September 25, 2020
Cardiol-PR Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart April 14, 2020
Search
Cardiol-PR
September 25, 2020
April 14, 2020
